Skip to main content

Ex vivo cell labelling for in vivo imaging applied to cell therapeutics

Project description

Noninvasive in vivo cell imaging technology

Development of cell therapies such as CAR-T and stem cells, would greatly benefit from the ability to non-invasively track and quantify cells infused into patients. The goal of this EU-funded project is to develop imaging beads for contrast enhancement (BEACONs) to label cell therapies ex vivo and measure biodistribution in vivo using non-invasive imaging technologies for use both preclinically and clinically. Recent advances in the field of cell therapies such as CAR-T and stem cell therapies coupled with the need for biodistribution data and greater safety during clinical trials create attractive markets for such cell tracking technology. Cenya is working with regulatory advisers to define a development plan and obtain broad regulatory approval of BEACONs for use with any type of cell therapy in humans.

Host institution

CENYA IMAGING B.V.
Net EU contribution
€ 150 000,00
Address
Tweede Kostverlorenkade 11h
1052RK Amsterdam
Netherlands

See on map

Region
West-Nederland Noord-Holland Groot-Amsterdam
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
No data

Beneficiaries (1)

CENYA IMAGING B.V.
Netherlands
Net EU contribution
€ 150 000,00
Address
Tweede Kostverlorenkade 11h
1052RK Amsterdam

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Region
West-Nederland Noord-Holland Groot-Amsterdam
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Non-EU contribution
No data